| 6.61 -0.07 (-1.05%) | 04-08 15:55 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.02 | 1-year : | 9.37 |
| Resists | First : | 6.86 | Second : | 8.02 |
| Pivot price | 6.46 |
|||
| Supports | First : | 6.38 | Second : | 6.09 |
| MAs | MA(5) : | 6.63  |
MA(20) : | 6.49 |
| MA(100) : | 6.24 |
MA(250) : | 7.09 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 71.7 |
D(3) : | 68.3 |
| RSI | RSI(14): 55 |
|||
| 52-week | High : | 9.28 | Low : | 5.38 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ UG ] has closed below upper band by 27.1%. Bollinger Bands are 0.8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.69 - 6.71 | 6.71 - 6.74 |
| Low: | 6.55 - 6.58 | 6.58 - 6.61 |
| Close: | 6.63 - 6.67 | 6.67 - 6.72 |
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.
Thu, 02 Apr 2026
UG Stock Price, Quote & Chart | UNITED GUARDIAN INC (NASDAQ:UG) - ChartMill
Tue, 31 Mar 2026
United-Guardian 2025 Earnings Fall Y/Y Amid Weak Sales Trends - TradingView
Mon, 30 Mar 2026
United-Guardian’s 2025 Profits Decline Year-Over-Year Due to Sluggish Sales Performance - Bitget
Fri, 27 Mar 2026
United-Guardian: Q4 Earnings Snapshot - KVUE
Fri, 27 Mar 2026
United-Guardian, Inc. Reports Decrease in FY 2025 Net Sales and Income Amidst Market Challenges - Quiver Quantitative
Fri, 27 Mar 2026
United-Guardian Reports 2025 Financial Results - ChartMill
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 5 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 36 (%) |
| Held by Institutions | 21.5 (%) |
| Shares Short | 8 (K) |
| Shares Short P.Month | 7 (K) |
| EPS | 0.43 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.29 |
| Profit Margin | 19.4 % |
| Operating Margin | 9.5 % |
| Return on Assets (ttm) | 10.2 % |
| Return on Equity (ttm) | 17.8 % |
| Qtrly Rev. Growth | -26 % |
| Gross Profit (p.s.) | 1.1 |
| Sales Per Share | 2.19 |
| EBITDA (p.s.) | 0.47 |
| Qtrly Earnings Growth | -69 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | 15.44 |
| PEG Ratio | 0 |
| Price to Book value | 2.88 |
| Price to Sales | 3.02 |
| Price to Cash Flow | 15.95 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 3.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|